Heartflow (NASDAQ:HTFL) Downgraded by Wall Street Zen to “Hold”

Wall Street Zen cut shares of Heartflow (NASDAQ:HTFL) from a buy rating to a hold rating in a research note released on Saturday morning,Wall Street Zen reports.

Other equities analysts have also recently issued reports about the stock. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research note on Friday, August 14th. Stifel Nicolaus boosted their price objective on shares of Heartflow from $40.00 to $45.00 and gave the stock a “buy” rating in a research report on Friday, August 14th. Morgan Stanley increased their target price on shares of Heartflow from $35.00 to $40.00 and gave the stock an “equal weight” rating in a report on Friday, August 14th. Benchmark reaffirmed a “buy” rating on shares of Heartflow in a research report on Friday, August 14th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of Heartflow in a research note on Wednesday. One investment analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $48.62.

Heartflow Stock Performance

NASDAQ:HTFL opened at $52.40 on Friday. The company has a market cap of $4.56 billion, a PE ratio of -28.63 and a beta of 2.50. Heartflow has a 52-week low of $20.13 and a 52-week high of $60.56. The stock has a 50-day simple moving average of $51.28 and a 200 day simple moving average of $34.64.

Heartflow (NASDAQ:HTFL) last announced its earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.22) by $0.15. The business had revenue of $64.08 million for the quarter. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%. Heartflow’s revenue was up 47.7% on a year-over-year basis. On average, research analysts predict that Heartflow will post -0.75 earnings per share for the current fiscal year.

Insider Buying and Selling at Heartflow

In other Heartflow news, CFO Vikram Verghese sold 29,714 shares of the business’s stock in a transaction that occurred on Friday, September 11th. The stock was sold at an average price of $50.06, for a total transaction of $1,487,482.84. Following the transaction, the chief financial officer owned 184,789 shares of the company’s stock, valued at $9,250,537.34. The trade was a 13.85% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 23,933 shares of the company’s stock in a transaction that occurred on Thursday, October 22nd. The stock was sold at an average price of $55.01, for a total value of $1,316,554.33. Following the sale, the insider owned 73,453 shares in the company, valued at approximately $4,040,649.53. This represents a 24.58% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 328,038 shares of company stock worth $15,490,354 over the last ninety days. 7.70% of the stock is currently owned by corporate insiders.

Institutional Trading of Heartflow

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its position in shares of Heartflow by 75.1% in the 3rd quarter. GAMMA Investing LLC now owns 641 shares of the company’s stock valued at $32,000 after acquiring an additional 275 shares during the period. IFP Advisors Inc raised its holdings in shares of Heartflow by 844.7% in the 3rd quarter. IFP Advisors Inc now owns 803 shares of the company’s stock valued at $40,000 after purchasing an additional 718 shares during the period. Allworth Financial LP raised its holdings in shares of Heartflow by 116.4% in the 3rd quarter. Allworth Financial LP now owns 1,145 shares of the company’s stock valued at $57,000 after purchasing an additional 616 shares during the period. Integrated Wealth Concepts LLC acquired a new stake in Heartflow in the 2nd quarter valued at about $53,000. Finally, Essential Partners LLC acquired a new stake in Heartflow in the 1st quarter valued at about $57,000.

Heartflow Company Profile

Heartflow, Inc is a medical technology company that develops artificial intelligence-based tools to help physicians diagnose and manage coronary artery disease. Its platform uses data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient’s coronary arteries and provide noninvasive assessments of blood flow and disease.

The company’s products include Heartflow Analysis, which provides fractional flow reserve computed tomography (FFR-CT) evaluations to help identify potentially significant blockages, as well as tools for assessing coronary plaque and planning treatment.